RxDoctor Payments Data

Gene Uhler, MD

Family Medicine · Coatesville, PANPI 1548229503

Payments from drug & device makers

$636in general payments, 2019–2025

Across 40 payments — averaging $15.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$101
  • Novo Nordisk$70
  • Boehringer Ingelheim$70
  • Amarin Pharma, Inc.$63
  • Pfizer$55
  • AbbVie$55
  • plus $223 from 10 others

What the payments were for

  • Food & beverage$636100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$636 in reported general payments places this provider in the 60th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$162,987
Medicare patients
500
Services billed
3,502

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban102$87,952
OzempicSemaglutide60$64,217
FarxigaDapagliflozin Propanediol49$43,133
JardianceEmpagliflozin46$37,974
TrulicityDulaglutide26$24,500
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$19,026
XareltoRivaroxaban13$18,976
VraylarCariprazine Hcl12$17,077
MyrbetriqMirabegron18$15,323
Breo ElliptaFluticasone/Vilanterol31$15,177
JanumetSitagliptin Phos/Metformin Hcl13$13,786
Atorvastatin Calcium837$8,559
Epinephrine18$4,885
Omeprazole395$4,395
Lantus SolostarInsulin Glargine,hum.Rec.Anlog43$4,204

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$55$87,952102 claims
Novo NordiskOzempic$70$64,21760 claims
AstraZenecaFarxiga, Symbicort$101$46,68463 claims
Boehringer IngelheimJardiance$70$37,97446 claims
GSKTrelegy Ellipta, Breo Ellipta$14$34,20245 claims
Lilly USA, LLCTrulicity$30$24,50026 claims
AbbVieVraylar, Synthroid$55$18,83259 claims
Astellas Pharma US IncMyrbetriq$17$15,32318 claims
MerckJanumet$46$13,78613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Coatesville

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →